Sonoma Pharmaceuticals Reports Fiscal Q2 Revenue Up 28%
Fiscal Q2 2027 revenue rose to $7.2 million from $5.6 million a year earlier. Pre-tax income was $382,000, compared with a $731,000 loss; net loss narrowed to $66,000 from $534,000.
Sonoma Pharmaceuticals reported fiscal Q2 2027 revenue of $7.2M, up 28% from $5.6M a year earlier, and pre-tax income of $382K versus a $731K loss. Net loss was $66K, compared with $534K a year earlier.Material DetailsContext by AI AnalystThis is an early profitability milestone following positive…